October 10, 2017 | Israeli clinical-stage biotechnology company Azura Ophthalmics has raised $16 million in a Series B funding round led by investors that include a syndicate of Orbimed, TPG Biotech, and Brandon Capital’s Medical Research Commercialization. There was also participation from existing investor Ganot Capital. The company, based in Tel Aviv, will use the […]